Armata Pharmaceuticals (ARMP) Stock Price, Quote, News & History | Benzinga

Armata Pharmaceuticals Inc (ARMP) Stock Price, Quote, News & History

ARMPAMEX

Trade with Public

Trade with Public

$5.33

-0.04-0.74%

Last update: Aug 31, 10:58 AM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$5.33

Close

-

Volume / Avg.

8.71K / 151.24K

Day Range

$5.26 - $5.36

52 Wk Range

2.40 - 16.34

Market Cap

$198.18M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

56

Short Interest

7.42%

Days to Cover

6.42

Recent Armata Pharmaceuticals, Inc. News

Why Is Armata Pharma Stock Gaining Monday?

ARMP stock jumps 10% as Armata Pharmaceuticals prepares its AP-SA02 multi-phage candidate for a pivotal Phase 3 trial in late 2026.

Vandana Singh

Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session

U.S. stock futures down, Zenas Biopharma shares fall 9.5% in pre-market trading due to pricing of public offerings. Other stocks also lower.

Avi Kapoor

Why LendingClub Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Universal Health Services Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers Silicon Motion Technology Corporation (NASDAQ: SIMO) shares climbed 78.9% to $93.40 following a report suggesting China approval of the company's Maxlinear merger.

Lisa Levin

Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers Tupperware Brands Corporation (NYSE: TUP) shares jumped 59% to $1.43 on above-average volume amid retail investor interest.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-25.42M

Investing Cash Flow (TTM)

-374.00K

Financing Cash Flow (TTM)

44.15M

Free Cash Flow (TTM)

-25.79M

Capital Expenditure (TTM)

-374.00K

Net Change in Cash (TTM)

18.35M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$489.67M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-98.51%

Earnings Yield % (FWD)

-85.10%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$6.22

Company Debt

Total Debt

$283.51M

LT Debt

$42.02M

LT Debt Issuance (TTM)

$40.00M

LT Debt Repayment (TTM)

-

Total Cash

$23.95M

Debt to Equity

-

Issuance of Debt (TTM)

$40.00M

Repayment of Debt (TTM)

-

Key Statistics

Open

$5.33

Close

-

Volume / Avg.

8.71K / 151.24K

Day Range

$5.26 - $5.36

52 Wk Range

2.40 - 16.34

Market Cap

$198.18M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

56

Short Interest

7.42%

Days to Cover

6.42

About

Sector

Health Care

Industry

Biotechnology

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial in...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Armata Pharmaceuticals (ARMP) stock?

A

You can purchase shares of Armata Pharmaceuticals (AMEX:ARMP) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Armata Pharmaceuticals (ARMP) competitors?

A

Other companies in Armata Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Armata Pharmaceuticals (ARMP) stock?

A

Armata Pharmaceuticals has a consensus price target of $15.00.

Q

What is the current price for Armata Pharmaceuticals (ARMP)?

A

The stock price for Armata Pharmaceuticals (AMEX: ARMP) is $5.33 last updated August 31, 2026 at 10:58 AM EDT.

Q

Does Armata Pharmaceuticals (ARMP) pay a dividend?

A

There are no upcoming dividends for Armata Pharmaceuticals.

Q

When is Armata Pharmaceuticals (AMEX:ARMP) reporting earnings?

A

Armata Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Armata Pharmaceuticals (ARMP) going to split?

A

There is no upcoming split for Armata Pharmaceuticals.

Q

What sector and industry does Armata Pharmaceuticals (ARMP) operate in?

A

Armata Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.